Jakarta – Scientists in China have identified a potential new biomarker for Parkinson’s disease in human hair, offering a less invasive method for early detection of the neurodegenerative condition. The research, led by biologist Ming Li of Hebei University, analyzed hair samples from 60 patients with Parkinson’s and compared them to those of healthy individuals of similar ages, revealing distinct differences in metal composition.
The study, published as a pre-proof paper in the journal iScience, found that hair from Parkinson’s patients exhibited significantly lower levels of iron and copper, but higher levels of manganese and arsenic, compared to the control group. This discovery could be a significant step forward in diagnosing Parkinson’s, a condition that often proves challenging to identify in its early stages. Early diagnosis is crucial for managing symptoms and potentially slowing disease progression.
Researchers highlighted the unique advantages of using hair as a biological sample. Unlike blood tests, which reflect a snapshot in time, hair accumulates metals and other substances from an individual’s diet and environment over a longer period. This creates a kind of “biological archive” that can provide insights into a person’s health over months or even years. This long-term record is particularly valuable for chronic conditions like Parkinson’s, where changes can develop gradually before noticeable symptoms appear.
The findings align with previous research linking Parkinson’s disease to factors such as gut microbiome imbalances and dietary habits. Exposure to environmental toxins, like pesticides, has also been identified as a potential risk factor. These factors can disrupt the body’s metabolism and potentially manifest in changes to hair composition, according to the study.
Further experiments conducted on mouse models reinforced these initial findings. The team found that mice exhibiting Parkinson’s-like symptoms also had reduced iron levels in their hair. This reduction was closely linked to impaired gut function, with damage to the intestinal walls and reduced activity of genes responsible for iron absorption. Conversely, genes that aid gut bacteria in absorbing iron showed increased activity, collectively contributing to iron deficiency in the mice.
This phenomenon mirrors observations in human Parkinson’s patients, where changes in gut bacteria composition, known as dysbiosis, are often detected years before diagnosis. This underscores the strong connection between gut health and the development of Parkinson’s, often referred to as the “gut-brain axis.” The research suggests hair may serve as a silent recorder of the complex interplay between the gut and the brain.
Among all the observed changes in mineral composition, the decrease in iron levels in hair was the most consistent finding, both in human patients and mouse models. This suggests that iron metabolism disruption, potentially triggered by gut issues, plays a central role in the development of Parkinson’s disease. Researchers concluded that the interplay between gut bacteria and iron processing within the body provides important initial evidence of the connection between these systems in Parkinson’s development.
Elevated levels of arsenic in the hair of Parkinson’s patients also drew attention from the research team. Arsenic is a known toxic heavy metal that can originate from environmental exposure, such as contaminated drinking water or food. While the study involved a limited number of participants, patients with Parkinson’s reported consuming organ meats and shellfish, such as clams, more frequently, foods known to potentially contain higher levels of arsenic. This raises the possibility that environmental arsenic exposure may contribute to the risk or progression of Parkinson’s and that hair could be a useful indicator for monitoring such exposure.
The study authors stated, “we speculate that decreased iron levels in hair are associated with gastrointestinal dysfunction in Parkinson’s patients, as found in many other studies, including gut bacterial imbalances showing a higher ability to absorb iron.” This statement reinforces the importance of the gut-iron metabolism connection in the context of Parkinson’s.
These findings are consistent with a scientific literature review published in 2025, which compiled evidence of disrupted iron levels in the brain, blood, and gut of Parkinson’s patients. This further strengthens the hypothesis that iron deficiency is not an isolated phenomenon, but an integral component of Parkinson’s disease affecting multiple systems within the body.
While these findings are promising, the researchers emphasize the need for further studies with a larger number of participants to confirm the results and gain a deeper understanding of how iron deficiency relates to the development of Parkinson’s. If proven accurate and reliable, this hair analysis method could revolutionize Parkinson’s diagnosis, potentially enabling earlier intervention and improved patient outcomes.
